Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zymeworks (ZYME) Current Assets (2021 - 2025)

Zymeworks' Current Assets history spans 5 years, with the latest figure at $248.8 million for Q4 2025.

  • On a quarterly basis, Current Assets fell 17.2% to $248.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $248.8 million, a 17.2% decrease, with the full-year FY2025 number at $248.8 million, down 17.2% from a year prior.
  • Current Assets hit $248.8 million in Q4 2025 for Zymeworks, down from $291.7 million in the prior quarter.
  • Over the last five years, Current Assets for ZYME hit a ceiling of $544.7 million in Q4 2022 and a floor of $190.7 million in Q3 2022.
  • Historically, Current Assets has averaged $348.2 million across 5 years, with a median of $343.8 million in 2024.
  • Biggest five-year swings in Current Assets: surged 96.5% in 2023 and later dropped 27.24% in 2024.
  • Tracing ZYME's Current Assets over 5 years: stood at $288.2 million in 2021, then surged by 88.99% to $544.7 million in 2022, then decreased by 24.19% to $412.9 million in 2023, then decreased by 27.24% to $300.5 million in 2024, then decreased by 17.2% to $248.8 million in 2025.
  • Business Quant data shows Current Assets for ZYME at $248.8 million in Q4 2025, $291.7 million in Q3 2025, and $296.1 million in Q2 2025.